ArticleTherapeutic advances in gastroenterology2018

Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint.

Brian E Lacy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.